Loading clinical trials...
Loading clinical trials...
Challenges Faced By Neurophysiotherapist While Consultation Through Telerehabilitation Within Maharashtra State- A Cross-Sectional Study
Being the most important stakeholder of such a vulnerable population, the neuro physiotherapist faced a lot of difficulties while consulting and assessing patients with neurological impairments. Up to our knowledge and search history, this is the first-ever study conducted by us which list out the challenges faced by neuro physiotherapist while teleconsultation mode among Indian population.
During the ongoing Covid-19 pandemic many Neurophysiotherapist opted for telerehabilitation to provide rehabilitation to the patients. This study aims to find out challenges faced by Neurophysiotherapist (NeuroPT) for consultation through telerehabilitation within Maharashtra provenance. A total of 103 NeuroPT within Maharashtra provenance were contacted through this online survey. A brief, structured and validated questionnaire was constructed as there is no gold standard questionnaire developed to obtain responses from the neuro physiotherapists opting for telerehabilitation mode for their consultations with their clients. The questionnaire was sent by What's app and email to gather basic information to describe the various challenges in consultation through telerehabilitation.
Age
25 - 65 years
Sex
ALL
Healthy Volunteers
Yes
MGM School Of Physiotherapy
Aurangabad, Maharashtra, India
Start Date
September 22, 2020
Primary Completion Date
January 31, 2021
Completion Date
January 31, 2021
Last Updated
September 8, 2021
103
ACTUAL participants
Opinions about tele-rehabilitation for consulting a clients with neurological impairments
OTHER
Lead Sponsor
Mahatma Gandhi Institute of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions